Pneumonia in patients with chronic lymphocytic leukemia treated with venetoclax‐based regimens: A real‐world analysis of Polish Adult Leukemia Group (PALG)
eJHaem · 2025-02 · 6 (1)
DOI: 10.1002/jha2.1042 ↗Kurz gefasst
Fachartikel in der Zeitschrift eJHaem, online erschienen am 04.11.2024. Verfasst von Elżbieta Kalicińska und 13 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Department of Hematology, Cell Therapies and Internal Diseases Wroclaw Medical University Wroclaw Poland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Patients with chronic lymphocytic leukemia (CLL) are susceptible to infections that can affect their clinical outcomes.
Aims
To assess: (1) the incidence of pneumonia in CLL patients treated with venetoclax‐based regimens in a real‐world setting, (2) the risk factors for event‐free survival (EFS), and (3) overall survival (OS).
Methods
This multicenter study included 322 patients from eight centers. Univariable and multivariable analyses (MVA) were performed, having the development of pneumonia during venetoclax‐based treatment and OS as outcomes.
Results
The most common complication was neutropenia (59%). During treatment with venetoclax‐based regimens, 66 (20%) of patients developed pneumonia: 50 (23%) patients in the rituximab plus venetoclax (R‐VEN) group, 13 (16%) patients in the obinutuzumab plus venetoclax (O‐VEN) group ( p = 0.15). Chronic obstructive pulmonary disease (COPD)/asthma, splenomegaly, elevated creatinine, and anemia
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Department of Hematology, Cell Therapies and Internal Diseases Wroclaw Medical University Wroclaw Poland.
- Experimental Hematooncology Department Medical University of Lublin Lublin Poland.
- Department of General Hematology Medical University of Lodz Lublin Poland.
- Department of Hematology, Transplantation and Internal Medicine Medical University of Warsaw Warsaw Poland.
- Department of Lymphoid Malignancies National Research Institute of Oncology Warsaw Poland.
- Department of Hematology Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń Toruń Poland.
ORCID-Profile: Elżbieta Kalicińska, Elżbieta Iskierka-Jażdżewska, Krzysztof Jamroziak
Zitieren
APA
Kalicińska, E., Jablonowska-Babij, P., Morawska, M., Iskierka-Jażdżewska, E., Drozd-Sokolowska, J., Paszkiewicz-Kozik, E., Szukalski, Ł., Strzała, J., Gosik, U., Dębski, J., Andrasiak, I., Skotny, A., Jamroziak, K., & Wrobel, T. (2025). Pneumonia in patients with chronic lymphocytic leukemia treated with venetoclax‐based regimens: A real‐world analysis of Polish Adult Leukemia Group (PALG). eJHaem, 6(1). https://doi.org/10.1002/jha2.1042
Vancouver
Kalicińska E, Jablonowska-Babij P, Morawska M, Iskierka-Jażdżewska E, Drozd-Sokolowska J, Paszkiewicz-Kozik E, et al. Pneumonia in patients with chronic lymphocytic leukemia treated with venetoclax‐based regimens: A real‐world analysis of Polish Adult Leukemia Group (PALG). eJHaem. 2025;6(1). doi:10.1002/jha2.1042
BibTeX
@article{Kaliciska2025,
author = {Kalicińska, Elżbieta and Jablonowska-Babij, Paula and Morawska, Marta and Iskierka-Jażdżewska, Elżbieta and Drozd-Sokolowska, Joanna and Paszkiewicz-Kozik, Ewa and Szukalski, Łukasz and Strzała, Judyta and Gosik, Urszula and Dębski, Jakub and Andrasiak, Iga and Skotny, Anna and Jamroziak, Krzysztof and Wrobel, Tomasz},
title = {Pneumonia in patients with chronic lymphocytic leukemia treated with venetoclax‐based regimens: A real‐world analysis of Polish Adult Leukemia Group (PALG)},
journal = {eJHaem},
year = {2025},
volume = {6},
number = {1},
doi = {10.1002/jha2.1042}
}
EUVIMED